Cancer cells thrive in an environment deprived of oxygen and nutrients, adapting to survive and grow. Unlike normal cells, ...

The strange world of organ preservation is spawning new tech firms. OrganOx has added impetus to the industry with a $142mn ...

19 Despite these challenges, exciting developments are emerging, such as integrating CRISPR diagnostics with machine learning to enhance accuracy and automate analysis. 20 Multiplexed detection ...

Take CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA), two biotechs specializing in gene editing. Finance, is $83.60; the latter earns a price target of $50.80 from ...

application for HG202 which is the world’s first-of-a-kind CRISPR/Cas13 RNA-editing therapy for clinical application in treatment for neovascular age-related macular degeneration (nAMD) developed by ...

Pediatric Clinical Trial MarketThe Clinical Trial Market is estimated to be worth USD 120.97 billion in 2024 and is projected ...

The Nucleic Acid Isolation and Purification Market is projected to be valued at USD 1,178.6 million in 2025 and is expected to grow at a CAGR of 5.6% from 2025 to 2035, reaching USD 2,038.1 million by ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

In addition, first-generation CRISPR systems (Cas9 and Cas12a) are too large for efficient in vivo delivery via a single adeno-associated viral (AAV) vector. Now, new preclinical research ...

The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions ...